Drug intelligence / Profile preview

CP-526423

Development stage
Unknown
Lead developer
Astellas Pharma
Modality
Small Molecules
01

Overview

CP-526423 is an experimental small molecule belonging to the class of indolecarboxamides and derivatives. Its chemical formula is C24H24Cl2N4O4 and it has a molecular weight of approximately 503.38 g/mol. The compound has been identified as a structure-based inhibitor targeting glycogen phosphorylase B, suggesting its potential use in modulating glucose metabolism or related pathways. There are no approved indications or marketed uses for this drug; it remains at the experimental stage with no reported clinical trial activity beyond preclinical research[1][4][2].

Other names
1,2-bis(2-(5-chloroindole-2-carbonylamino)ethoxy)ethanebis[5-chloro-1h-indol-2-yl-carbonyl-aminoethyl]-ethylene glycolN,N'-[1,2-Ethanediylbis(oxy-2,1-ethanediyl)]bis(5-chloro-1H-indole-2-carboxamide)
02

Targets

PYGL (Glycogen phosphorylase, liver form)

Beyond the preview

Go deeper on CP-526423.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on CP-526423.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call